π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The purpose of this Expanded Access Program (EAP) is to enable the use of 8...
Status
No Longer Available
Location
Arkansas Urology
Start Date
TBD
Trial ID
NCT06090331
Treatments Being Tested
The study is a phase 2, non-comparative and non-randomized, single arm, nat...
Status
Recruiting
Location
IRCCS Ospedale San Raffaele
Start Date
2026-02-25
Trial ID
NCT07171905
Treatments Being Tested
A prospective, open-label, phase 2 study to explore CAIX expression through...
Status
Terminated
Location
University of California, Los Angeles(UCLA)
Start Date
2023-06-06
Trial ID
NCT05563272
Treatments Being Tested
The goal of this clinical trial is to learn whether 89Zr-Girentuximab PET s...
Status
Not Yet Recruiting
Location
Massachusetts General Hospital
Start Date
2026-09-16
Trial ID
NCT07077083
Treatments Being Tested
The purpose of this study is to identify changes in Carbonic Anhydrase IX (...
Status
Recruiting
Location
NYU Langone Health
Start Date
2025-09-15
Trial ID
NCT07179770
Treatments Being Tested
89Zr-TLX250 is a carbonic anydrase IX (CAIX)-targeted imaging agent that is...
Status
Completed
Location
Yokohama City University Hospital
Start Date
2020-08-01
Trial ID
NCT04496089
Treatments Being Tested
Precision medicine represents a major goal in oncology. It has its underpin...
Status
Recruiting
Location
CHU de Nantes
Start Date
2025-11-04
Trial ID
NCT06735560
Treatments Being Tested
89Zr-TLX250 is under clinical development as a diagnostic agent targeting c...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-11-06
Trial ID
NCT06750419
Treatments Being Tested
The study is designed to explore the safety and tolerability as well as dia...
Status
Completed
Location
Radboud University
Start Date
2018-04-05
Trial ID
NCT03556046
Treatments Being Tested
The purpose of this study is to evaluate the use of 89Zr-labeled girentuxim...
Status
Completed
Location
ICO RenΓ© Gauducheau
Start Date
2021-09-21
Trial ID
NCT04758780
Treatments Being Tested